Doma Perpetual Capital Management LLC boosted its stake in shares of Afya Limited (NASDAQ:AFYA - Free Report) by 92.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 567,109 shares of the company's stock after purchasing an additional 272,200 shares during the period. Afya makes up approximately 4.5% of Doma Perpetual Capital Management LLC's portfolio, making the stock its 8th biggest holding. Doma Perpetual Capital Management LLC owned approximately 0.61% of Afya worth $9,006,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in the stock. State Street Corp increased its position in Afya by 118.2% during the 3rd quarter. State Street Corp now owns 73,098 shares of the company's stock worth $1,248,000 after purchasing an additional 39,592 shares in the last quarter. Teacher Retirement System of Texas acquired a new stake in shares of Afya in the fourth quarter worth $329,000. Wellington Management Group LLP purchased a new position in shares of Afya in the 4th quarter valued at $829,000. Renaissance Technologies LLC lifted its holdings in shares of Afya by 14.0% during the 4th quarter. Renaissance Technologies LLC now owns 412,000 shares of the company's stock valued at $6,543,000 after acquiring an additional 50,700 shares in the last quarter. Finally, Van ECK Associates Corp boosted its position in Afya by 41.9% during the 4th quarter. Van ECK Associates Corp now owns 9,677 shares of the company's stock worth $154,000 after purchasing an additional 2,856 shares during the period. Institutional investors and hedge funds own 88.02% of the company's stock.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on AFYA shares. Citigroup restated a "sell" rating and issued a $15.00 target price (down from $18.00) on shares of Afya in a research note on Friday, January 31st. JPMorgan Chase & Co. decreased their target price on Afya from $25.00 to $20.50 and set a "neutral" rating for the company in a research report on Friday, January 17th. Finally, Morgan Stanley downgraded shares of Afya from an "equal weight" rating to an "underweight" rating and lowered their price objective for the company from $19.00 to $17.00 in a research report on Tuesday, March 11th. Three research analysts have rated the stock with a sell rating and two have assigned a hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Reduce" and an average price target of $17.60.
Read Our Latest Stock Analysis on Afya
Afya Stock Performance
NASDAQ:AFYA traded up $0.48 during mid-day trading on Friday, hitting $18.58. The stock had a trading volume of 210,952 shares, compared to its average volume of 122,358. The company has a 50 day simple moving average of $17.51 and a 200-day simple moving average of $16.70. Afya Limited has a 52 week low of $14.52 and a 52 week high of $20.06. The stock has a market capitalization of $1.74 billion, a price-to-earnings ratio of 14.98, a P/E/G ratio of 0.29 and a beta of 0.66. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 0.51.
Afya Announces Dividend
The business also recently declared a -- dividend, which was paid on Friday, April 4th. Shareholders of record on Wednesday, March 26th were issued a $0.232 dividend. The ex-dividend date was Wednesday, March 26th. Afya's dividend payout ratio is currently 17.69%.
Afya Profile
(
Free Report)
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Further Reading

Before you consider Afya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.
While Afya currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.